Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Tue, Feb 4, 2025
[Archive]
Volume 12 - Case Supplement
Caspian J Intern Med 2021, 12 - Case Supplement : 407-412 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Farokhi P, Sadeghi A, Moghaddas A, HeidarPour M, Dinari S. Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer. Caspian J Intern Med 2021; 12 (S2) :407-412
URL: http://caspjim.com/article-1-2285-en.html
URL: http://caspjim.com/article-1-2285-en.html
Assistant Professor of Clinical Pharmacy, Department of Clinical Pharmacy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. , azadeh_moghaddas@yahoo.com
Abstract: (2460 Views)
Background: Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, radiotherapy and surgical resection of the tumor were proposed for the management of patients suffering from SCC of the pancreas.
Case Presentation: In this report, we introduced a 57-year-old man who was diagnosed with SCC of the pancreas along with liver metastasis. The patient underwent surgical resection and several adjuvant systemic chemotherapies including fluorouracil and taxane based regimens which were led to the 13- month overall survival.
Conclusion: Although, the patients died from underlying tumor, the survival time before death was one of the longest time/period reported.
Case Presentation: In this report, we introduced a 57-year-old man who was diagnosed with SCC of the pancreas along with liver metastasis. The patient underwent surgical resection and several adjuvant systemic chemotherapies including fluorouracil and taxane based regimens which were led to the 13- month overall survival.
Conclusion: Although, the patients died from underlying tumor, the survival time before death was one of the longest time/period reported.
Type of Study: case report |
Subject:
Oncology
Received: 2020/04/15 | Accepted: 2020/10/3 | Published: 2021/07/24
Received: 2020/04/15 | Accepted: 2020/10/3 | Published: 2021/07/24
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
